Bromoacetylcholine bromide,
22004-27-9,
17139-54-7,
2-(2-Bromoacetyloxy)-N.,N,N-trimethylethanaminium bromide,
EU-0100196,
MLS002153520,
SCHEMBL1320993,
CHEMBL1255831,
CTK4D3929,
HMS2233F19,
HMS3260H13,
REGID_for_CID_11957478,
Tox21_500196,
MFCD00078570,
CCG-221500,
LP00196,
ACM17139547,
NCGC00093672-01,
NCGC00260881-01,
SMR000326753,
B-121,
SR-01000075729,
J-014415,
SR-01000075729-1,
Ethanaminium,2-[(2-bromoacetyl)oxy]-N,N,N-trimethyl-,
2-(2-Bromoacetyloxy)-N,N,N-trimethylethanaminium bromide,
Bromoacetylcholine,
2-Bromoacetylcholine,
C7H15BrNO2,
Choline, bromoacetate (ester),
C7-H15-Br-N-O2,
BRN 1778727,
CID11957478,
E1001,
2-((Bromoacetyl)oxy)-N,N,N-trimethylethanaminium,
BROMOACETYLCHOLINE BROMIDE INHIBITOR OF CHOLINE,
Ethanaminium, 2-((bromoacetyl)oxy)-N,N,N-trimethyl-,